| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Jan 25 | LSTA Lisata Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 15,789 | 0.00 | 74,469 |
| 25 Sep 24 | DRRX DURECT | Stock Option Common Stock | Grant | Acquire A | No | No | 1.22 | 5,500 | 6.71 k | 5,500 |
| 9 Jan 24 | LSTA Lisata Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 19,480 | 0.00 | 58,680 |
| 19 Dec 23 | XENE Xenon Pharmaceuticals | Common Shares | Option exercise | Acquire M | No | No | 9.85 | 3,497 | 34.45 k | 74,225 |
| 19 Dec 23 | XENE Xenon Pharmaceuticals | Common Shares | Option exercise | Acquire M | No | No | 9.85 | 823 | 8.11 k | 70,728 |
| 19 Dec 23 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Option exercise | Dispose M | No | No | 9.85 | 3,497 | 34.45 k | 0 |
| 19 Dec 23 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Option exercise | Dispose M | No | No | 9.85 | 823 | 8.11 k | 0 |
